A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression
Crossref DOI link: https://doi.org/10.1007/s10549-014-3014-7
Published Online: 2014-06-12
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Jangsoon
Bartholomeusz, Chandra
Mansour, Oula
Humphries, Juliane
Hortobagyi, Gabriel N.
Ordentlich, Peter
Ueno, Naoto T.
Text and Data Mining valid from 2014-06-12